Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Evolutionary modeling warns of COVID-19 vaccine resistance

Aug. 2, 2021

Deuterated GC-376 variants show efficacy in model of SARS-CoV-2 infection

Aug. 2, 2021

Enyo reports promising phase II data for vonafexor in patients with chronic hepatitis B

Aug. 2, 2021

SymBio opens phase IIa study of brincidofovir in subjects with adenovirus infection

July 30, 2021

S2X259, novel human MAb with potential to overcome the emergence of SARS-CoV-2 variants

July 30, 2021

AUG-3387 binds and neutralizes the SARS-CoV-2 Delta variant in vitro

July 30, 2021

Vaxart's oral norovirus vaccine boosts immune responses in previously vaccinated subjects

July 30, 2021

COVIDITY-001 study of SCOV-1 and SCOV-2 vaccine candidates approved in South Africa

July 30, 2021

Daewoong reports phase IIb topline data on Foistar in mild COVID-19

July 29, 2021

Venatorx reports phase I data on beta-lactamase inhibitor VNRX-7145

July 29, 2021

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.